We also found that the specific hypomethylation of the promoter site -783 CpG of the PPARGC1A gene, measured though pyrosequencing, may represent a biomarker of reduced insulin sensitivity after the ingestion of glucose and a possible predictor of future T2D risk. The gene discussed is PPARGC1A; the disease is type 2 diabetes mellitus.